HEMATOLOGIC NEOPLASMS
Clinical trials for HEMATOLOGIC NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC NEOPLASMS trials appear
Sign up with your email to follow new studies for HEMATOLOGIC NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could less be more? new study aims to make transplants safer for blood cancer patients
Disease control OngoingThis study looks at whether a lower dose of the drug cyclophosphamide, given after a stem cell transplant, can help control blood cancers like leukemia and lymphoma with fewer side effects. About 105 people aged 15-65 with high-risk blood cancers will receive a transplant from a …
Matched conditions: HEMATOLOGIC NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
Could dropping one drug make stem cell transplants safer?
Disease control OngoingThis study looks at whether it is safe to remove one immune-suppressing drug, mycophenolate mofetil (MMF), from the standard treatment plan after a stem cell transplant for blood cancers. Sixty adults aged 18 to 75 will receive the transplant without MMF and be monitored for up t…
Matched conditions: HEMATOLOGIC NEOPLASMS
Phase: PHASE2 • Sponsor: Ronald Paquette • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC